In ex vivo studies, NK cells from patients with COVID-19 displayed impaired cytotoxicity (64, 65), potentially due to cytokine dysregulation and high plasma levels of interleukin-6 and tumor necrosis factor–α (66). The gene discussed is IL6; the disease is COVID-19.